MICHELLE PORTER: Open Payments
NPI 1366102386 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$968 in 36 payments from 17 companies in 2025. Trend: 2023 $319 · 2024 $826 · 2025 $968
Food & beverage: $968
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 3 | $159 |
| Merck Sharp & Dohme LLC | 6 | $128 |
| Tempus AI, Inc | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $64 |
| Genentech USA, Inc. | 3 | $59 |
| Genmab U.S., Inc. | 2 | $52 |
| PFIZER INC. | 3 | $51 |
| Lilly USA, LLC | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $44 |
Products named: Orserdu, XT CDX, KEYTRUDA, LYNPARZA, IBRANCE, IMFINZI, ELZONRIS, VERZENIO.
Industry payments across OH — which companies pay providers there.
